Direktorat Registrasi ObatValid

SILDENAFIL CITRATE

BPOM Number: GKL2507926817B1
Approved: 25 October 2025
Expiry: 24 October 2030
Form: TABLET SALUT SELAPUT

About This Registration

SILDENAFIL CITRATE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL2507926817B1. Its current registration status is Valid, with the licence valid until 24 October 2030. The product is registered to HARSEN LABORATORIES - INDONESIA. BPOM first approved this registration in October 2025. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application: newaero
Packaging: DUS, 1 BLISTER @ 2 TABLET SALUT SELAPUT
Department: Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

HARSEN LABORATORIES - INDONESIA
KODYA JAKARTA TIMUR
NPWP: 12345678910
owner
View profile →

Manufacturing Sites

HARSEN LABORATORIES - INDONESIA
KODYA JAKARTA TIMUR
primary
View profile →

Ingredients (1)

SILDENAFIL CITRATE

Market Intelligence

Owner Portfolio: HARSEN LABORATORIES - INDONESIA holds 138 BPOM registrations
Manufacturer Scale: HARSEN LABORATORIES - INDONESIA produces 138 registered products
Registration Age: Registered for 10 months

FDA Cross-Reference

via openFDA

Generic Name: SILDENAFIL CITRATE
Product Type: HUMAN PRESCRIPTION DRUG
Route of Administration: ORAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?